NDC codes

413472 NDC codes with hospital pricing data in the network.

• NDC 00019-0953-23 — Iothalamate meglumine 60% contrast injectionAI (109 hospitals, 58–130 samples)
• NDC 00143-9542-01 — NICARDIPINE 25 MG/10 ML INTRAVENOUS SOLUTIONAI (163 hospitals, 13–130 samples)
• NDC 25021-0229-05 — Cytarabine injection, 20 mg/mLAI (194 hospitals, 112–130 samples)
• NDC 63323-0812-01 — Oxacillin 2 gram injectionAI (159 hospitals, 112–130 samples)
• NDC 72205-0265-01 — Phenylephrine 10 mg/mL injectionAI (50 hospitals, 13–130 samples)
• NDC 72603-0363-01 — Ampicillin 1 gram injection solutionAI (83 hospitals, 13–130 samples)
• NDC 172362648 — Doxycycline hyclate 100 mg tabletsAI (17 hospitals, 13–130 samples)
• NDC 182153589 — Doxycycline 100 mg tabletAI (19 hospitals, 13–130 samples)
• NDC 2821591 — Regular insulin, 1000-unit vialAI (30 hospitals, 13–130 samples)
• NDC 338954124 — Metronidazole 500 mg intravenous infusion bagAI (69 hospitals, 13–130 samples)
• NDC 378113401 — KETOROLAC 10 MG TABLETAI (77 hospitals, 13–130 samples)
• NDC 409781137 — Metronidazole intravenous solution 500 mg per 100 mLAI (63 hospitals, 13–130 samples)
• NDC 591555305 — Doxycycline 100 mg tabletAI (17 hospitals, 13–130 samples)
• NDC 591555350 — Doxycycline hyclate 100 mg tabletsAI (17 hospitals, 13–130 samples)
• NDC 71080540 — Gabapentin 300 mg capsulesAI (34 hospitals, 13–130 samples)
• NDC 781540601 — Lorazepam 1 mg tabletAI (30 hospitals, 13–130 samples)
• NDC 904043061 — Doxycycline 100 mg tabletsAI (19 hospitals, 13–130 samples)
• NDC 904598161 — Lorazepam 1 mg tabletAI (27 hospitals, 13–130 samples)
• NDC 00069-0104-01 — Doxycycline hyclate injectionAI (41 hospitals, 13–130 samples)
• NDC 00074-1159-01 — INJECTION, BUPIVICAINE, NOT OTHERWISE SPECIFIED, 0.5 MG (3 hospitals, 13–130 samples)
• NDC 00469-2290-20 — Protamine sulfate injection, per 10 mgAI (12 hospitals, 13–130 samples)
• NDC 50111-0608-01 — KETOROLAC 10 MG TABLETAI (48 hospitals, 13–130 samples)
• NDC 51079-0386-21 — Lorazepam 1 mg tabletAI (40 hospitals, 13–130 samples)
• NDC 66220-0160-10 — Conivaptan in dextrose solutionAI (307 hospitals, 112–130 samples)
• NDC 68084-0742-01 — Lorazepam 1 mg tabletAI (59 hospitals, 13–130 samples)
• NDC 70121-1390-07 — Fosphenytoin injection, 500 mg per 10 mLAI (116 hospitals, 13–130 samples)
• NDC 72603-0363-10 — Ampicillin 1 gram injection solutionAI (87 hospitals, 13–130 samples)
• NDC 641047721 — Phenobarbital sodium injection, 130 mg/mLAI (83 hospitals, 13–130 samples)
• NDC 00069-2392-10 — COVID-19 vaccine 2023-2024 formula, ages 12 and upAI (55 hospitals, 13–130 samples)
• NDC 00338-4302-04 — Fibrin sealant topical kit, 4 mLAI (39 hospitals, 13–130 samples)
• NDC 00338-4303-10 — Topical blood-clotting kit, 10 mLAI (28 hospitals, 13–130 samples)
• NDC 00517-2650-25 — Magnesium sulfate IV injectionAI (30 hospitals, 13–130 samples)
• NDC 00781-3343-09 — LEVOFLOXACIN INJECTIONAI (21 hospitals, 13–130 samples)
• NDC 00781-3829-96 — Glycopyrrolate injection 0.2 mg/mL, 5 mL vialAI (68 hospitals, 13–130 samples)
• NDC 00944-4302-04 — FIBRIN SEALANT COMPONENT KIT 4 ML (9 hospitals, 13–130 samples)
• NDC 25021-0127-66 — Ceftazidime 1 gram injection solutionAI (158 hospitals, 13–130 samples)
• NDC 47335-0936-40 — Leuprolide acetate injection kitAI (128 hospitals, 112–130 samples)
• NDC 55150-0233-10 — Fondaparinux sodium 10 mg injectionAI (336 hospitals, 13–130 samples)
• NDC 58468-4663-01 — Imiglucerase 400-unit vialAI (374 hospitals, 112–130 samples)
• NDC 63323-0578-12 — Glycopyrrolate 0.4 mg/2 mL injectionAI (102 hospitals, 13–130 samples)
• NDC 63459-0601-06 — Arsenic trioxide intravenous solutionAI (312 hospitals, 130 samples)
• NDC 70710-1833-01 — Levothyroxine sodium injection 100 mcgAI (160 hospitals, 112–130 samples)
• NDC 71837-5843-05 — Sargramostim injection vialAI (330 hospitals, 112–130 samples)
• NDC 0074501501 — Risankizumab 60 mg/mL intravenous solutionAI (60 hospitals, 13–130 samples)
• NDC 0143931601 — Levofloxacin 500 mg IV infusion in dextroseAI (57 hospitals, 13–130 samples)
• NDC 0143931624 — Levofloxacin 500 mg IV infusion in dextroseAI (41 hospitals, 13–130 samples)
• NDC 0143972001 — Levofloxacin 750 mg IV piggyback in dextroseAI (65 hospitals, 13–130 samples)
• NDC 0143972024 — Levofloxacin 750 mg IV piggyback in dextroseAI (65 hospitals, 13–130 samples)
• NDC 0143972101 — Levofloxacin 500 mg antibiotic IV infusion in dextroseAI (81 hospitals, 13–130 samples)
• NDC 0143972124 — Levofloxacin 500 mg IV infusion in dextroseAI (65 hospitals, 13–130 samples)